10.1007/s40097-020-00331-3

Antimicrobial effect of chitosan–silver–copper nanocomposite on Candida albicans

Show Details XML HTML PDF
  • Mohsen Ashrafi1,
  • Mansour Bayat*2,
  • Pejman Mortazavi3,
  • Seyed Jamal Hashemi4,
  • Amir Meimandipour5,
  1. Department of Pathobiology, Faculty of Veterinary Specialized Sciences Science and Research Branch, Islamic Azad University, Tehran, IR
  2. Department of Microbiology, Faculty of Veterinary Specialized Sciences, Science and Research Branch, Islamic Azad University, Tehran, IR
  3. Department of Pathology, Faculty of Specialized Veterinary Sciences, Science and Research Branch, Islamic Azad University, Tehran, IR
  4. Department of Medical Parasitology and Mycology, School of Public Health, Tehran University of Medical Sciences, Tehran, IR
  5. Department of Industrial and Environmental Biotechnology, National Institute of Genetic Engineering and Biotechnology, Tehran, IR
Cover Image

Published in Issue 29-01-2020

How to Cite

Ashrafi, M., Bayat, M., Mortazavi, P., Hashemi, S. J., & Meimandipour, A. (2020). Antimicrobial effect of chitosan–silver–copper nanocomposite on Candida albicans. Journal of Nanostructure in Chemistry, 10(1 (March 2020). https://doi.org/10.1007/s40097-020-00331-3
Crossref
Scopus
Google Scholar
Europe PMC

HTML views: 25

PDF views: 140

Abstract

Abstract Candida is a common yeast in opportunistic fungal diseases around the world and is usually colonized on the skin and mucosal membranes. The purpose of this study was to synthesize chitosan–silver–copper nanocomposite and to investigate its antifungal effects on Candida albicans . Silver, copper and chitosan nanoparticles were synthesized individually. Then, copper–silver–chitosan nanocomposite was synthesized. These nanoparticles are approved by transmission electron microscope, and nanocomposite structure was also confirmed by scanning electron microscope. Then, the minimum inhibitory concentrations and minimum fungicidal of these nanostructures were examined on C. albicans . The results of this study indicate that the properties and effects of the investigated nanocomposite are comparable to amphotericin B as standard material. The results show that this effect was higher for copper–silver–chitosan nanocomposite than for other nanoparticles studied. Antifungal effect of copper nanoparticles and chitosan nanoparticles was not established separately, but it was found that their composition had antifungal effects that were effective. The combination of nanoparticles of chitosan with silver has been shown to have some antifungal effects. The most antifungal effect for the nanoparticles studied is related to copper–silver–chitosan nanocomposite and, which has had a significant effect on the growth of C. albicans in the laboratory environment compared to other nanoparticles. Graphic abstract

Keywords

  • Candida albicans,
  • Chitosan,
  • Silver,
  • Copper,
  • Nanocomposite
HTML PDF

References

  1. Vázquez-González et al. (2013) Opportunistic yeast infections: candidiasis, cryptococcosis, trichosporonosis and geotrichosis 11(5) (pp. 381-394)
  2. Dalle et al. (2010) Cellular interactions of Candida albicans with human oral epithelial cells and enterocytes 12(2) (pp. 248-271)
  3. Healy et al. (2008) Fluconazole prophylaxis in extremely low birth weight neonates reduces invasive candidiasis mortality rates without emergence of fluconazole-resistant Candida species 121(4) (pp. 703-710)
  4. Lim et al. (2012) Candida and invasive candidiasis: back to basics 31(1) (pp. 21-31)
  5. Miceli et al. (2011) Emerging opportunistic yeast infections 11(2) (pp. 142-151)
  6. Eslami et al. (2019) Mycobacterium avium paratuberculosis and Mycobacterium avium complex and related subspecies as causative agents of zoonotic and occupational diseases 234(8) (pp. 12415-12421)
  7. Shafiei et al. (2019) Risk factors and control strategies for silicotuberculosis as an occupational disease (pp. 75-77)
  8. Salerno et al. (2011) Candida-associated denture stomatitis 16(2) (pp. e139-e143)
  9. Hani et al. (2015) Candidiasis: a fungal infection-current challenges and progress in prevention and treatment 15(1) (pp. 42-52)
  10. Fidel (2002) Immunity to candida (pp. 69-75)
  11. Kothavade et al. (2010) Candida tropicalis: its prevalence, pathogenicity and increasing resistance to fluconazole 59(8) (pp. 873-880)
  12. Khan et al. (2012) Gold nanoparticles enhance methylene blue–induced photodynamic therapy: a novel therapeutic approach to inhibit Candida albicans biofilm
  13. Yousefi et al. (2019) Probiotics can really cure an autoimmune disease?
  14. Ghasemian et al. (2018) Probiotics and their increasing importance in human health and infection control 29(4) (pp. 153-158)
  15. Espitia et al. (2012) Zinc oxide nanoparticles: synthesis, antimicrobial activity and food packaging applications 5(5) (pp. 1447-1464)
  16. Palza (2015) Antimicrobial polymers with metal nanoparticles 16(1) (pp. 2099-2116)
  17. Eslami and Peyghan (2015) DNA nucleobase interaction with graphene like BC3 nano-sheet based on density functional theory calculations (pp. 52-56)
  18. Eslami et al. (2016) Sensing properties of BN nanotube toward carcinogenic 4-chloroaniline: a computational study (pp. 6-11)
  19. Mohammed et al. (2017) An overview of chitosan nanoparticles and its application in non-parenteral drug delivery 9(4)
  20. Youssef et al. (2019) Rational design and electrical study of conducting bionanocomposites hydrogel based on chitosan and silver nanoparticles (pp. 886-894)
  21. El-Aziz et al. (2019) Preparation and characterization of chitosan/polyacrylic acid/copper nanocomposites and their impact on onion production (pp. 856-865)
  22. Burdușel et al. (2018) Biomedical applications of silver nanoparticles: an up-to-date overview 8(9)
  23. Youssef et al. (2016) Biological studies and electrical conductivity of paper sheet based on PANI/PS/Ag-NPs nanocomposite (pp. 333-343)
  24. Heiligtag and Niederberger (2013) The fascinating world of nanoparticle research 16(7) (pp. 262-271) https://doi.org/10.1016/j.mattod.2013.07.004
  25. Chen and Sorrell (2007) Antifungal agents 187(7)
  26. Kumar, V.V., Anthony, S.P.: Antimicrobial studies of metal and metal oxide nanoparticles. In: Kumar, V.V., Anthony, S.P. (eds.) Surface Chemistry of Nanobiomaterials, pp. 265–300. Elsevier (2016)
  27. Mavani and Shah (2013) Synthesis of silver nanoparticles by using sodium borohydride as a reducing agent 2(3) (pp. 1-5)
  28. Shameli et al. (2011) Synthesis and characterization of silver/montmorillonite/chitosan bionanocomposites by chemical reduction method and their antibacterial activity
  29. Suramwar et al. (2016) One pot synthesis of copper nanoparticles at room temperature and its catalytic activity (pp. S1807-S1812)
  30. Anand et al. (2018) Synthesis of chitosan nanoparticles by TPP and their potential mosquito larvicidal application 2(2) (pp. 72-78)
  31. Liang et al. (2019) The size-controllable preparation of chitosan/silver nanoparticle composite microsphere and its antimicrobial performance (pp. 22-29)
  32. Caston-Osorio et al. (2008) Epidemiology of invasive fungal infection (pp. S103-S109)
  33. Haynes (2001) Virulence in Candida species 9(12) (pp. 591-596)
  34. De Pauw et al. (2008) Revised definitions of invasive fungal disease from the European organization for research and treatment of cancer/invasive fungal infections cooperative group and the national institute of allergy and infectious diseases mycoses study group (EORTC/MSG) consensus group 46(12) (pp. 1813-1821)
  35. Jones (2001) Resistance patterns among nosocomial pathogens: trends over the past few years 119(2) (pp. 397S-404S)
  36. Salek Farrokhi et al. (2019) Is it true that gut microbiota is considered as panacea in cancer therapy? 234(9) (pp. 14941-14950)
  37. Yousefi et al. (2019) Probiotics importance and their immunomodulatory properties 234(6) (pp. 8008-8018)
  38. Kell et al. (2013) The promiscuous binding of pharmaceutical drugs and their transporter-mediated uptake into cells: what we (need to) know and how we can do so 18(5–6) (pp. 218-239)
  39. Lara et al. (2015) Effect of silver nanoparticles on Candida albicans biofilms: an ultrastructural study 13(1)
  40. Helander et al. (2001) Chitosan disrupts the barrier properties of the outer membrane of Gram-negative bacteria 71(2–3) (pp. 235-244)
  41. Gajbhiye et al. (2009) Fungus-mediated synthesis of silver nanoparticles and their activity against pathogenic fungi in combination with fluconazole 5(4) (pp. 382-386)
  42. Kim et al. (2008) Antifungal effect of silver nanoparticles on dermatophytes 18(8) (pp. 1482-1484)
  43. El-Rafie et al. (2010) Antimicrobial effect of silver nanoparticles produced by fungal process on cotton fabrics 80(3) (pp. 779-782)
  44. Panwar et al. (2016) Efficacy of ferulic acid encapsulated chitosan nanoparticles against Candida albicans biofilm (pp. 21-31)
  45. Kulatunga et al. (2016) Chitosan silver nanocomposite (CAgNC) as an antifungal agent against Candida albicans 55(2) (pp. 213-222)
  46. Ing et al. (2012) Antifungal activity of chitosan nanoparticles and correlation with their physical properties https://doi.org/10.1155/2012/632698
  47. Karimiyan, A., Najafzadeh, H., Ghorbanpour, M., Hekmati-Moghaddam, S.H.: Antifungal effect of magnesium oxide, zinc oxide, silicon oxide and copper oxide nanoparticles against
  48. Candida albicans
  49. . ZJRMS
  50. 17
  51. (10) (2015)